Neurovascular Complications of Antiphospholipid Syndrome: A Narrative Review
Author Information
Author(s): George Nilton Nunes Mendes, Alessandra Braga Cruz Guedes, Laura Catherine Gioia, Grégory Jacquin, Alexandre Y. Poppe, Felipe Hideki Soga, João Brainer Clares de Andrade
Primary Institution: Université de Montréal, Centre Hospitalier, Programme de Santé Neurovasculaire, Montréal Québec, Canada.
Hypothesis
To comprehensively review relevant and updated clinical aspects of neurovascular manifestations of APS.
Conclusion
Understanding the complex interplay of neurovascular manifestations in APS is essential for guiding clinical decisions and improving patient outcomes.
Supporting Evidence
- Stroke is a prevalent complication in APS, with arterial thrombosis being a predominant mechanism.
- Direct oral anticoagulants have not shown superiority over vitamin K antagonists for secondary prevention in APS patients.
- Cognitive impairment affects a considerable proportion of APS patients, with thrombotic and nonthrombotic mechanisms contributing to its pathophysiology.
Takeaway
Antiphospholipid syndrome can cause serious brain problems like strokes and memory issues, and doctors need to find better ways to help patients with these challenges.
Methodology
A narrative review using PubMed, EMBASE, and Cochrane Library databases focusing on studies published in English from January 1, 2015, to March 2024.
Potential Biases
Potential bias due to the exclusion of non-English studies and reliance on published literature.
Limitations
The review may not include all relevant studies and focuses primarily on English-language publications.
Participant Demographics
Patients with antiphospholipid syndrome, including those with ischemic stroke and cognitive impairment.
Statistical Information
P-Value
p=0.033
Confidence Interval
95% CI: 1.5–30.5
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website